EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Chinese Patent Medicine Ameliorate Ulcerative Colitis in Mice by Restoring the Th17/Treg Balance

Tao Zhang, Xiaolan Su, Yanli Huang, Yujing Wang, Lin Wang, Gengqing Song, Wei Wei

Gut Medicine · 2025

DOI: 10.1002/gtm2.70005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Gut Medicine, 2025. Verfasst von Tao Zhang und 6 weiteren Autor:innen. Die Arbeit nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objective In China, Weichang'an Pill (WCAP) is a drug marketed for mild and moderate active ulcerative colitis (UC) but its mechanism is unknown. In the present study, the anti‐inflammatory mechanism of WCAP was investigated.

Methods

Dextran sulfate sodium (DSS) was used to induce UC in mice, which were divided into 4 groups ( n = 6), control, DSS, WCAP, and mesalazine. Pure water, WCAP, or mesalazine suspension was administered by gavage. UC severity was evaluated based on body weight, disease activity index (DAI), colon length, and colonic histological score. Percentage of Th17 and Treg cells and cytokine and transcription factor (TF) levels in colonic tissues were detected using flow cytometry, ELISA, IHC, and qRT‐PCR, respectively.

Results

Compared with the DSS group, body weight, DAI, colon length, and histological score were significantly improved in the WCAP group, and the Treg/Th17 ratio in the spleens and mesenteric lymph nodes (MLNs) of UC mice was similar in WCAP and control groups. In the WCAP group, IL‐6, IL‐1β, TNF‐α, IL‐17A, STAT3, P‐STAT3, ROR‐γt mRNA, and P‐NF‐κB p65 levels and number of ROR‐γt‐positive cells in colonic tissues were decreased; however, TGF‐β1, IL‐10, and Foxp3 mRNA levels and number of Foxp3‐positive cells were increased. Statistical difference among indicators was not found between mesalazine and WCAP groups ( p > 0.05).

Conclusions

WCAP significantly improved body weight, DAI, colon length, and histological score in UC mice and demonstrated effects similar to mesalazine. The anti‐inflammatory mechanism may involve the recovery of Th17/Treg balance and pro/anti‐inflammatory cytokine and TF regulation.

Zitieren

APA

Zhang, T., Su, X., Huang, Y., Wang, Y., Wang, L., Song, G., & Wei, W. (2025). Chinese Patent Medicine Ameliorate Ulcerative Colitis in Mice by Restoring the Th17/Treg Balance. Gut Medicine. https://doi.org/10.1002/gtm2.70005

Vancouver

Zhang T, Su X, Huang Y, Wang Y, Wang L, Song G, et al. Chinese Patent Medicine Ameliorate Ulcerative Colitis in Mice by Restoring the Th17/Treg Balance. Gut Medicine. 2025. doi:10.1002/gtm2.70005

BibTeX
@article{Zhang2025,
  author = {Zhang, Tao and Su, Xiaolan and Huang, Yanli and Wang, Yujing and Wang, Lin and Song, Gengqing and Wei, Wei},
  title = {Chinese Patent Medicine Ameliorate Ulcerative Colitis in Mice by Restoring the Th17/Treg Balance},
  journal = {Gut Medicine},
  year = {2025},
  doi = {10.1002/gtm2.70005}
}
Kostenlos starten →